Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck.

[1]  M. Todaro,et al.  Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy. , 2013, Cancer research.

[2]  M. Suntharalingam,et al.  Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03). , 2007, International journal of radiation oncology, biology, physics.

[3]  Wilson Roa,et al.  Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Aapro,et al.  Preclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia. , 2007, European journal of cancer.

[5]  M. Pepe,et al.  Do erythropoietin receptors on cancer cells explain unexpected clinical findings? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Kevin Wei,et al.  VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis , 2006, Nature Medicine.

[7]  Michael Höckel,et al.  Impact of Hemoglobin Levels on Tumor Oxygenation: the Higher, the Better? , 2006, Strahlentherapie und Onkologie.

[8]  B. Zackrisson,et al.  Recombinant erythropoietin β enhances growth of xenografted human squamous cell carcinoma of the head and neck after surgical trauma , 2006, Acta oto-laryngologica.

[9]  J. Baselga,et al.  Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Grandis,et al.  Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma , 2005, Oncogene.

[11]  M. Arcasoy,et al.  Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  T. Chow,et al.  Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin. , 2004, Molecular cancer therapeutics.

[13]  C. Koch,et al.  Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells. , 2004, Cancer letters.

[14]  T. Chow,et al.  Erythropoietin receptor expression in biopsy specimens from patients with uterine cervix squamous cell carcinoma , 2004, International Journal of Gynecologic Cancer.

[15]  M. Rose,et al.  Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy. , 2004, Current hematology reports.

[16]  Ahmed Mohyeldin,et al.  Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. , 2003, The American journal of pathology.

[17]  Yoshiko Yasuda,et al.  Erythropoietin regulates tumour growth of human malignancies. , 2003, Carcinogenesis.

[18]  Y. Brandberg,et al.  Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy , 2003, Cancer.

[19]  G. Demetri,et al.  Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy , 2002, Cancer.

[20]  G. Acs,et al.  Erythropoietin and erythropoietin receptor expression in human cancer. , 2001, Cancer research.

[21]  C. Westenfelder,et al.  Erythropoietin stimulates proliferation of human renal carcinoma cells. , 2000, Kidney international.

[22]  C. Grau,et al.  Significance of Hemoglobin Concentration for Treatment Outcome , 2000 .

[23]  H. Goldschmidt,et al.  Recombinant human erythropoietin in the treatment of cancer. , 2000, Antibiotics and chemotherapy.

[24]  D. Ribatti,et al.  Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. , 1999, Blood.

[25]  Epoetin alfa improves quality of life , 1998 .

[26]  J. Kugler,et al.  Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. , 1993, Journal of the National Cancer Institute.

[27]  R. Abels.  Recombinant human erythropoietin in the treatment of the anaemia of cancer. , 1992, Acta haematologica.